This was posted on another forum, thought people might find this interesting.
Look at AXIM Biotechologies
Oct 24tgh 2016 AXIM was trading at 40 cents....3 montsh later Jan 12th 2017, $19.80
They are in the cannabinoid delivery system (As is VIN)...
They make no money and have no money:
Earning a current market cap value of $772M, AXIM has $870k in cash on the books, which stands against about $4.1M total current liabilities. AXIM is effectively pre-revenue at this point.
About AXIM
AXIM® Biotechnologies, Inc. (OTC:AXIM) focuses on the research, development and production of cannabis-based pharmaceutical, nutraceutical and cosmetic products.
AXIM Biotechnologies Inc. has made a name for itself by creating unique delivery systems for cannabinoids. For example, the company's cannabinoid-infused chewing gum provides extended release for conditions like chronic pain, while its cannabinoid-containing toothpaste is designed to treat infection and gum disease. The company is working toward full FDA/EMA registration for one of its products as early as 2018 with the rest coming soon after.
======
VIN
About MJ Biopharma
MJ Biopharma is a cannabis technology company with a team of highly experienced business and medical professionals, biochemists and researchers. The company is currently focused on the following areas of interest:
Manufacturing breath strips;
Time-release capsules;
Extract oils;
Food products, and infused juices, teas, coffee and extract drinks;
Pharmaceutical-grade delivery systems.
MJ Biopharma's expertise lies in its extracts and custom formulations. The company will also aim to in-license and joint venture on best-in-class technologies and products for both the medicinal and recreational markets -- domestically and internationally.
